Format

Send to

Choose Destination
See comment in PubMed Commons below
BMC Vet Res. 2012 Nov 21;8:225. doi: 10.1186/1746-6148-8-225.

Efficacy of clarithromycin on biofilm formation of methicillin-resistant Staphylococcus pseudintermedius.

Author information

1
School of Engineering, University of Guelph, Ontario, Canada.

Abstract

BACKGROUND:

Surgical site infections (SSIs) caused by biofilm-forming methicillin-resistant Staphylococcus pseudintermedius (MRSP) have emerged as the most common hospital-acquired infections in companion animals. No methods currently exist for the therapeutic remediation of SSIs caused by MRSP in biofilms. Clarithromycin (CLA) has been shown to prevent biofilm formation by Staphylococcus aureus. This study aims to assess the in vitro activity of CLA in eradicating MRSP biofilm formation on various materials.

RESULTS:

Quantitative assay results (P = 0.5126) suggest that CLA does not eradicate MRSP biofilm formation on polystyrene after 4 - 24 h growth periods. Scanning electron micrographs confirmed that CLA did not eradicate MRSP biofilm formed on orthopaedic implants.

CONCLUSIONS:

By determining the in vitro characteristics and activities of MRSP isolates alone and against antibiotics, in vitro models of biofilm related infections can be made. In vitro data suggests that CLA does not effectively eradicate S. pseudintermedius biofilms in therapeutic doses.

PMID:
23171620
PMCID:
PMC3534386
DOI:
10.1186/1746-6148-8-225
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for BioMed Central Icon for PubMed Central
    Loading ...
    Support Center